Details
Stereochemistry | RACEMIC |
Molecular Formula | C9H13NO3 |
Molecular Weight | 183.2044 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCC(O)C1=CC(O)=C(O)C=C1
InChI
InChIKey=UCTWMZQNUQWSLP-UHFFFAOYSA-N
InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3
Molecular Formula | C9H13NO3 |
Molecular Weight | 183.2044 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Racepinephrine or racemic epinephrine is a mixture of levo and dextro isomers of epinephrine act as a nonselective agonist at adrenergic receptors. It is a bronchodilator used in the temporary relief of mild symptoms of intermittent asthma including wheezing, shortness of breath. Inhaled racepinephrine became available in September 2012 as a nonprescription treatment for bronchospasm based on a 1986 US Food and Drug Administration rule. Besides, racemic epinephrine relieves respiratory distress in hospitalized infants with bronchiolitis and is safe but does not abbreviate hospital stay. Morbidity associated with bronchiolitis as identified by parents persists for at least one week after hospital discharge in most infants.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2331074 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22220172 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseFor temporary relief of mild symptoms of intermittent asthma: wheezing, tightness of chest, shortness of breath |
|||
Palliative | Unknown Approved UseUnknown |
Doses
Dose | Population | Adverse events |
---|---|---|
50 mg single, oral Overdose |
unknown, 2 years n = 1 Health Status: unknown Age Group: 2 years Sex: M Population Size: 1 Sources: |
Disc. AE: Hypertension, Tachycardia... AEs leading to discontinuation/dose reduction: Hypertension (5.4%) Sources: Tachycardia (5.4%) |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Hypertension | 5.4% Disc. AE |
50 mg single, oral Overdose |
unknown, 2 years n = 1 Health Status: unknown Age Group: 2 years Sex: M Population Size: 1 Sources: |
Tachycardia | 5.4% Disc. AE |
50 mg single, oral Overdose |
unknown, 2 years n = 1 Health Status: unknown Age Group: 2 years Sex: M Population Size: 1 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor. | 1993 Dec |
|
Carazolol: a potent, selective beta 3-adrenoceptor agonist. | 1995 Nov 30 |
|
Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. | 1998 Apr 1 |
|
A comparison of effects measured with isotonic and isometric recording: II. Concentration-effect curves for physiological antagonists. | 2001 Aug |
|
The role of angiotensin II in regulating catecholamine secretion during hypoxia in rainbow trout Oncorhynchus mykiss. | 2001 Dec |
|
The calibre of the foramen of Panizza in Crocodylus porosus is variable and under adrenergic control. | 2001 May |
|
[Endoscopic mucosal resection of premalignant lesions of the upper gastrointestinal tract]. | 2001 Nov |
|
Arginine inhibits hemostasis activation. | 2001 Nov 15 |
|
Epinephrine reduces the sedative side effects of epidural sufentanil for labour analgesia. | 2002 Jan |
|
The efficacy of hemodynamic and T-wave criteria for detecting intravascular injection of epinephrine test dose in propofol-anesthetized adults. | 2002 Mar |
|
[Experimental study of puerarin injection on the hemorheology in acute blood-stasis model rats]. | 2003 Dec |
|
Cardiovascular and autonomic responses to lower body negative pressure: do not explain gender differences in orthostatic tolerance. | 2003 Feb |
|
[Surface architectonics and cytoskeleton of erythrocytes and their modulation by adrenergic agents in patients with bronchial asthma]. | 2004 |
|
Cytotoxic effects of gingival retraction cords on human gingival fibroblasts in vitro. | 2004 Apr |
|
Long-term stability study of L-adrenaline injections: Kinetics of sulfonation and racemization pathways of drug degradation. | 2004 Apr |
|
Cardiovascular responses of Chinook salmon (Oncorhynchus tshawytscha) during rapid anaesthetic induction and recovery. | 2004 Feb |
|
Extravasation of blood-borne immunoglobulin G through blood-brain barrier during adrenaline-induced transient hypertension in the rat. | 2004 Jun |
|
MAPK-dependent regulation of IL-1- and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress response. | 2004 Sep 21 |
|
Single dose oral clonidine premedication does not enhance postoperative, single low dose epidural morphine analgesia in hysterectomy patients. | 2005 Mar |
|
Opposite changes in imidazoline I2 receptors and alpha2-adrenoceptors density in rat frontal cortex after induced gliosis. | 2005 Nov 26 |
|
[Experimental studies of rhizoma Astilbes chinensis on its effects in abirritation, blood activation, cough relieving and sputum elimination]. | 2006 Dec |
|
Putting theory into practice: James Black, receptor theory and the development of the beta-blockers at ICI, 1958-1978. | 2006 Jan |
|
Strategies for enantioseparations of catecholamines and structurally related compounds by capillary zone electrophoresis using sulfated beta-cyclodextrins as chiral selectors. | 2006 Sep |
|
Extracellular signal-regulated kinase 1/2-mediated transcriptional regulation of G-protein-coupled receptor kinase 3 expression in neuronal cells. | 2007 Apr |
|
N,N-Bis(2-bromo-ethyl)aniline. | 2007 Dec 6 |
|
More PKA independent beta-adrenergic signalling via cAMP: is Rap1-mediated glucose uptake in vascular smooth cells physiologically important? | 2007 Jun |
|
End-column chemiluminescence detection for pressurized capillary electrochromatographic analysis of norepinephrine and epinephrine. | 2007 Nov 2 |
|
Analysis of the antimicrobial activity of local anaesthetics used for dental analgesia. | 2008 Jan |
|
Neuronal nitric oxide synthase gene inactivation reduces the expression of vasopressin in the hypothalamic paraventricular nucleus and of catecholamine biosynthetic enzymes in the adrenal gland of the mouse. | 2008 Jan |
|
Analysis of efficacy of chiral adrenergic agonists. | 2008 Mar |
|
Caffeine and anaerobic performance: ergogenic value and mechanisms of action. | 2009 |
|
Adrenaline-induced chronic ocular hypertension in adult rabbits. | 2009 Apr |
|
Simultaneous separation of epinephrine and norepinephrine enantiomers by EKC: application to the analysis of pharmaceutical formulations. | 2009 Aug |
|
Simultaneous determination of epinephrine, uric acid and xanthine in the presence of ascorbic acid using an ultrathin polymer film of 5-amino-1,3,4-thiadiazole-2-thiol modified electrode. | 2009 Aug 4 |
|
The impact of platelet function or C-reactive protein, on cardiovascular events after an acute myocardial infarction. | 2009 Jul 7 |
|
Enhanced voltammetric detection of epinephrine at a carbon nanotube/nafion composite electrode in the presence of ascorbic acid. | 2009 Nov |
|
Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization. | 2009 Sep |
|
Job insecurity and change over time in health among older men and women. | 2010 Jan |
|
Calcium deficiency in the early stages after weaning is associated with the enhancement of a low level of adrenaline-stimulated lipolysis and reduction of adiponectin release in isolated rat mesenteric adipocytes. | 2010 Jul |
|
Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study. | 2010 Mar |
|
A comparative study of intrathecal and epidural buprenorphine using combined spinal-epidural technique for caesarean section. | 2010 May |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/show/NCT00817466
Bronchiolitis: 0,1ml<5kg, 0,15ml 5-6,9kg, 0,20ml 7-9,9kg, 0,25ml >10kg of racemic adrenaline (racepinephrine) 20mg/ml diluted in 2ml NaCl. Maximum 12 inhalations/24 hours
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Sun Dec 18 19:37:39 UTC 2022
by
admin
on
Sun Dec 18 19:37:39 UTC 2022
|
Record UNII |
GR0L9S3J0F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
66887
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | RxNorm | ||
|
DTXSID80858965
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
4553
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
8059-19-6
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
SUPERSEDED | |||
|
CHEMBL1740
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
GR0L9S3J0F
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
SUB10238MIG
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
4508
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
206-347-6
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
C76546
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
DB11124
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
33568
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
329-65-7
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
M4944
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | Merck Index | ||
|
6912-68-1
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
SUPERSEDED | |||
|
8060-13-7
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
SUPERSEDED | |||
|
838
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY | |||
|
GR0L9S3J0F
Created by
admin on Sun Dec 18 19:37:40 UTC 2022 , Edited by admin on Sun Dec 18 19:37:40 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |